https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-13 / Cancer Immunol. Immunother. 2009 Aug;58(8):1257-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-13 / Cancer Immunol. Immunother. 2009 Aug;58(8):1257-642009-01-13 00:00:002019-02-15 08:44:20Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-522009-01-12 00:00:002019-02-15 08:49:55Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-672009-01-09 00:00:002019-02-15 08:44:28Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Acta Oncol 2009;48(3):452-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Acta Oncol 2009;48(3):452-62009-01-01 00:00:002009-01-01 00:00:00Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Recent Results Cancer Res. 2009;179:301-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Recent Results Cancer Res. 2009;179:301-192009-01-01 00:00:002009-01-01 00:00:00Current concepts in the management of retroperitoneal soft tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Folia Biol. (Praha) 2009;55(4):119-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Folia Biol. (Praha) 2009;55(4):119-252009-01-01 00:00:002019-02-15 08:53:16Dendritic cell-based immunotherapy induces transient clinical response in advanced rat fibrosarcoma – comparison with preventive anti-tumour vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Klin Onkol 2009;22(2):67-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Klin Onkol 2009;22(2):67-722009-01-01 00:00:002019-02-15 08:50:58[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Methods Mol. Biol. 2009;542:565-605
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Methods Mol. Biol. 2009;542:565-6052009-01-01 00:00:002021-11-15 17:03:01Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Cell. Immunol. 2009;257(1-2):23-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Cell. Immunol. 2009;257(1-2):23-312009-01-01 00:00:002019-02-15 08:50:13Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Electromagn Biol Med 2009;28(2):148-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Electromagn Biol Med 2009;28(2):148-652009-01-01 00:00:002019-02-15 09:17:31Oncothermia treatment of cancer: from the laboratory to clinic
